From the viewpoint of safety, while the incidence of grade 3 to 4 toxicity was not statistically significant between the two groups, neutropenia was still frequently observed in group A. This side-effect may be due to suppression of the release of granulocytes by IFN-α2b in the bone marrow (26). The gene discussed is IFNA2; the disease is Decreased total neutrophil count.